Coldstream Capital Management Inc 89bio, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in 89bio, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 45 shares of ETNB stock, worth $373. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45Holding current value
$373% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ETNB
# of Institutions
193Shares Held
139MCall Options Held
212KPut Options Held
1.06M-
Janus Henderson Group PLC London, X016.5MShares$137 Million0.07% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$118 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$84.7 Million3.26% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$62.1 Million0.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$59.5 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $386M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...